A comprehensive review of noninvasive liver fibrosis tests in pediatric nonalcoholic Fatty liver disease
- PMID: 26031832
- DOI: 10.1007/s11894-015-0447-z
A comprehensive review of noninvasive liver fibrosis tests in pediatric nonalcoholic Fatty liver disease
Abstract
Nonalcoholic fatty liver disease (NAFLD) and its spectrum ranging from simple steatosis to nonalcoholic steatohepatitis (NASH) and fibrosis have been increasing in the pediatric population. The presence and severity of fibrosis in patients with NAFLD are important prognostic factors for the risk of disease progression to cirrhosis. The gold standard for staging liver fibrosis is a liver biopsy. However, given the risks of this procedure, especially in the pediatric population, the development of noninvasive markers to diagnose and monitor progression of NAFLD is desirable. This paper will review recently developed noninvasive methods for diagnosing liver fibrosis in children with NAFLD. These include simple fibrosis scores, advanced biochemical markers, and radiologic imaging studies. Simple fibrosis scores use readily available laboratory tests; available one include AST/ALT ratio, AST to platelet ratio index (APRI), fibrosis (FIB)-4 index, NAFLD fibrosis score (NFS), pediatric NAFLD fibrosis index (PNFI), and pediatric NALFD fibrosis score (PNFS). Advanced biochemical markers include biomarkers of hepatocyte cell death such as cytokeratin 18 fragment levels, and markers of extracellular matrix turnover such as the Enhanced Liver Fibrosis (ELF) test and hyaluronic acid. Radiologic imaging studies estimate liver stiffness as a surrogate for liver fibrosis; these include transient elastography (TE), magnetic resonance elastography (MRE), and acoustic radiation force impulse imaging (ARFI).
Similar articles
-
Steatosis severity affects the diagnostic performances of noninvasive fibrosis tests in nonalcoholic fatty liver disease.Liver Int. 2018 Feb;38(2):331-341. doi: 10.1111/liv.13549. Epub 2017 Sep 5. Liver Int. 2018. PMID: 28796410
-
The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease.Dig Dis Sci. 2015 May;60(5):1440-7. doi: 10.1007/s10620-014-3494-7. Epub 2014 Dec 25. Dig Dis Sci. 2015. PMID: 25540086
-
Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.Dig Dis Sci. 2018 Sep;63(9):2259-2266. doi: 10.1007/s10620-018-5123-3. Epub 2018 May 19. Dig Dis Sci. 2018. PMID: 29779083
-
Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis.Hepatology. 2017 Nov;66(5):1486-1501. doi: 10.1002/hep.29302. Epub 2017 Sep 26. Hepatology. 2017. PMID: 28586172 Review.
-
Liver fibrosis markers of nonalcoholic steatohepatitis.World J Gastroenterol. 2015 Jun 28;21(24):7427-35. doi: 10.3748/wjg.v21.i24.7427. World J Gastroenterol. 2015. PMID: 26139988 Free PMC article. Review.
Cited by
-
Diagnosis of Fibrosis Using Blood Markers and Logistic Regression in Southeast Asian Patients With Non-alcoholic Fatty Liver Disease.Front Med (Lausanne). 2021 Feb 23;8:637652. doi: 10.3389/fmed.2021.637652. eCollection 2021. Front Med (Lausanne). 2021. PMID: 33708783 Free PMC article.
-
Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions.World J Gastroenterol. 2016 Sep 28;22(36):8078-93. doi: 10.3748/wjg.v22.i36.8078. World J Gastroenterol. 2016. PMID: 27688650 Free PMC article. Review.
-
Prevalence and Risk Factors for Hepatic Steatosis in Children With Perinatal HIV on Early Antiretroviral Therapy Compared to HIV-Exposed Uninfected and HIV-Unexposed Children.Front Pediatr. 2022 Jun 9;10:893579. doi: 10.3389/fped.2022.893579. eCollection 2022. Front Pediatr. 2022. PMID: 35757117 Free PMC article.
-
NAFLD in children: new genes, new diagnostic modalities and new drugs.Nat Rev Gastroenterol Hepatol. 2019 Sep;16(9):517-530. doi: 10.1038/s41575-019-0169-z. Epub 2019 Jul 5. Nat Rev Gastroenterol Hepatol. 2019. PMID: 31278377 Review.
-
A clinical model to predict fibrosis on liver biopsy in paediatric subjects with nonalcoholic fatty liver disease.Clin Obes. 2021 Oct;11(5):e12472. doi: 10.1111/cob.12472. Epub 2021 Jun 9. Clin Obes. 2021. PMID: 34106515 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical